Advisory Services Network’s Bionano Genomics BNGO Stock Holding History

Advisory Services Network’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$95	–	1725
2023 Q4	$95	Buy	+1	New	+$104	﹤0.01%	3782
2021 Q1	–	Sell	-3	Closed	-$6K	–	1480
2020 Q4	$6K	Buy	3 +1	+50%	+$374	﹤0.01%	2628
2020 Q3	$1K	Buy	+2	New	+$775	﹤0.01%	3273
2020 Q2	–	Sell	-2	Closed	–	–	1236
2020 Q1	$0	Buy	+2	New	+$1.13K	﹤0.01%	3042

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisory Services Network's BNGO Position: Q1 2024 in Review

Advisory Services Network sold out of Bionano Genomics (BNGO) in Q1 2024, closing a stake of 1 share — an estimated $95 sold.

Advisory Services Network first reported a position in BNGO in Q1 2020 and held it in 4 quarters. The position peaked at $6K in Q4 2020. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

Advisory Services Network reported no remaining Bionano Genomics position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 1 Bionano Genomics share in Q1 2024, an estimated $95.
Advisory Services Network first reported a position in Bionano Genomics in Q1 2020 and held it in 4 quarters.
Advisory Services Network's Bionano Genomics position peaked at $6K in Q4 2020.
55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.